Frequency and predictors of contrast-induced nephropathy after angioplasty for chronic total occlusions

International Journal of Cardiology

Volumn 139, Issue 1, 2010, Pages 68-74

  Aguiar Souto, Pablo ^a   Ferrante, Giuseppe ^a   Del Furia, Francesca ^a   Barlis, Peter ^a   Khurana, Rohit ^a   Di Mario, Carlo ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Chronic total occlusion; Contrast induced nephropathy; Percutaneous coronary intervention

Indexed keywords

ACETYLCYSTEINE; IODIXANOL; IOPROMIDE; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHRONIC TOTAL OCCLUSION; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; ECHOCARDIOGRAPHY; FEMALE; FLUID THERAPY; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CHRONIC DISEASE; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CREATININE; FEMALE; HUMANS; INCIDENCE; KIDNEY FAILURE, ACUTE; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 75849161574     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.10.006     Document Type: Article

References (46)

1. Di Mario C., Werner G.S., Sianos G., et al. for the EuroCTO club. European perspective in the recanalisation of Chronic Total Occlusions (CTO): consensus document from the EuroCTO Club. EuroInterv 3 (2007) 30-43
2. Nash K., Hafeez A., and Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 39 (2002) 930-936
3. Bouzas-Mosquera A., Vázquez-Rodríguez J.M., Calviño-Santos R., et al. Contrast-induced nephropathy and acute renal failure following emergent cardiac catheterization: incidence, risk factors and prognosis. Rev Esp Cardiol 60 (2007) 1010-1014
4. Marenzi G., Lauri G., Assanelli E., et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 44 (2004) 1780-1785
5. McCullough P.A., Wolyn R., Rocher L.L., Levin R.N., and O'Neill W.W. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 103 (1997) 368-375
6. Gruber L. Clinical features and prognostic implications of contrast-induced nephropathy. In: Bartorelli A.L., and Marenzi G. (Eds). Contrast-induced nephropathy (2006), Taylor & Francis, London 35-45
7. Bartholomew B.A., Harjai K.J., Dukkipati S., et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 93 (2004) 1515-1519
8. Gupta R., Gurm H.S., Bhatt D.L., Chew D.P., and Ellis S.G. Renal failure after percutaneous coronary intervention is associated with high mortality. Catheter Cardiovasc Interv 64 (2005) 442-448
9. Rihal C.S., Textor S.C., Grill D.E., et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105 (2002) 2259-2264
10. Tepel M., van der G.M., Schwarzfeld C., Laufer U., and Liermann D. SIDEC W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343 (2000) 180-184
11. Gruberg L., Mintz G.S., Mehran R., et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 36 (2000) 1542-1548
12. Brindis R.G., Fitzgerald S., Anderson H.V., Shaw R.E., Weintraub W.S., and Williams J.F. The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR): building a national clinical data repository. J Am Coll Cardiol 37 (2001) 2240-2245
13. Harjai K.J., Raizada A., Shenoy C., et al. A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system. Am J Cardiol 101 (2008) 812-819
14. Mehran R., Aymong E.D., Nikolsky E., et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44 (2004) 1393-1399
15. Dangas G., Iakovou I., Nikolsky E., et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 95 (2005) 13-19
16. Barlis P., Kaplan S., Dimopoulos K., Tanigawa J., Schultz C., and Di Mario C. An indeterminate occlusion duration predicts procedural failure in the recanalization of coronary chronic total occlusions. Catheter Cardiovasc Interv 71 (2008) 621-628
17. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
18. Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 130 (1999) 461-470
19. Brown J.R., DeVries J.T., Piper W.D., et al. Serious renal dysfunction after percutaneous coronary interventions can be predicted. Am Heart J 155 (2008) 260-266
20. Nikolsky E., Mehran R., Turcot D., et al. Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. Am J Cardiol 94 (2004) 300-305
21. Laskey W.K., Jenkins C., Selzer F., et al. Volume-to-creatinine clearance ratio. A pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. J Am Coll Cardiol 50 (2007) 584-590
22. Cigarroa R.G., Lange R.A., Williams R.H., and Hillis L.D. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 86 (1989) 649-652
23. Freeman R.V., O'Donnell M.O., Share D., et al. Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 90 (2002) 1068-1073
24. Meharn R., and Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int 69 (2006) S11-S15
25. Rihal C.S., Textor S.C., Grill D.E., et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105 (2002) 2259-2264
26. Weisbord S.D., Hartwig K.C., Sonel A.F., Fine M.J., Palevsky P., et al. The incidence of clinically significant contrast-induced nephropathy following non-emergent coronary angiography. Catheter Cardiovasc Interv 15 (2008)
27. Bartorelli A.L., and Marenzi G. Contrast-induced nephropathy. J Interv Cardiol 21 (2008) 74-85
28. Briguori C., Airoldi F., D'Andrea D., et al. Renal insufficiency following contrast media administration trial (REMEDIAL) a randomized comparison of 3 preventive strategies. Circulation 115 (2007) 1211-1217
29. Mueller C. Prevention of contrast-induced nephropathy with volume supplementation. Kidney Int 69 Suppl S100 (2006) S16-S19
30. Solomon R. Contrast-medium-induced acute renal failure. Kidney Int 53 (1998) 230-242
31. Marenzi G., Assanelli E., Marana I., et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Eng J Med 354 (2006) 2773-2782
32. Zagler A., Azadpour M., Mercado C., and Hennekens C.H. N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials. Am Heart J 151 (2006) 140-145
33. Barrett B.J., and Carlisle E.J. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 188 (1993) 171-178
34. Aspelin P., Aubry P., Fransson S.G., et al. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348 (2003) 491-499
35. Solomon R.J., Natarajan M.K., Doucet S., et al. Cardiac angiography in renally impaired patients (CARE) study. A randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation 115 (2007) 3189-3196
36. From A.M., Bartholmai B.J., Williams A.W., and McDonald F.S. Iodixanol compared to iohexol for contrast procedures: a case-matched retrospective cohort study. Acta Radiol 49 (2008) 409-414
37. Kimmel M., Butscheid M., Brenner S., Kuhlmann U., Klotz U., and Alscher D.M. Improved estimation of glomerular filtration rate by serum cystatin C in preventing contrast induced nephropathy by N-acetylcysteine or zinc-preliminary results. Nephrol Dial Transplant 23 (2008) 1241-1245
38. Albert S.G., Shapiro M.J., Brown W.W., et al. Analysis of radiocontrast-induced nephropathy by dual-labeled radionuclide clearance. Invest Radiol 29 (1994) 618-623
39. Diaz-Sandoval L.J., Kosowsky B.D., and Losordo D.W. Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). Am J Cardiol 89 (2002) 356-358
40. Kahn J.K., Rutherford B.D., McConahay D.R., et al. High-dose contrast agent administration during complex coronary angioplasty. Am Heart J 120 (1990) 533-536
41. Rosovsky M.A., Rusinek H., Berenstein A., et al. High-dose administration of nonionic contrast media: a retrospective review. Radiology 200 (1996) 119-122
42. Di Mario C., Barlis P., Tanigawa J., et al. Retrograde approach to coronary chronic total occlusions: preliminary single European centre experience. EuroInterv 3 (2007) 181-187
43. Sianos G., Barlis P., Di Mario C., et al. European experiences with the retrograde approach for the recanalisation of coronary artery chronic total occlusions. A report on behalf of the EuroCTO club. EuroInterv 4 (2008) 84-92
44. Stevens M.A., McCullough P.A., Tobin K.J., et al. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study: prevention of radiocontrast induced nephropathy clinical evaluation. J Am Coll Cardiol 33 (1999) 403-411
45. Guitterez N.V., Diaz A., Timmis G.C., et al. Determinants of serum creatinine trajectory in acute contrast nephropathy. J Interv Cardiol 15 (2002) 349-354
46. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150